Patient-derived xenografts as in vivo models for research in urological malignancies

Key Points Lack of appropriate models that recapitulate the complexity and heterogeneity of urological tumours precludes most of the preclinical reagents that enter clinical trials from achieving regulatory approval Patient-derived xenograft (PDX) models are characterized by direct engraftment of pa...

Ausführliche Beschreibung